A detailed history of William B. Walkup & Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, William B. Walkup & Associates, Inc. holds 4,179 shares of BMY stock, worth $241,880. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,179
Previous 3,636 14.93%
Holding current value
$241,880
Previous $151 Million 43.19%
% of portfolio
0.13%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $21,535 - $28,100
543 Added 14.93%
4,179 $216 Million
Q2 2024

Aug 15, 2024

BUY
$40.25 - $52.99 $146,349 - $192,671
3,636 New
3,636 $151 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track William B. Walkup & Associates, Inc. Portfolio

Follow William B. Walkup & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William B. Walkup & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on William B. Walkup & Associates, Inc. with notifications on news.